Starling Oncology Institute Inc (STLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,094 | 30,280 | 33,565 | 27,658 | 30,292 |
| Receivables | 66,709 | 59,450 | 59,320 | 59,978 | 55,935 |
| Inventories | 20,011 | 24,290 | 16,875 | 18,882 | 15,786 |
| TOTAL | $128,990 | $116,863 | $112,747 | $110,092 | $104,792 |
| Non-Current Assets | |||||
| PPE Net | 10,583 | 10,697 | 10,684 | 10,714 | 10,854 |
| Intangibles | 16,815 | 17,530 | 18,245 | 18,962 | 19,679 |
| Other Non-Current Assets | 21,845 | 23,140 | 22,980 | 23,851 | 24,473 |
| TOTAL | $49,243 | $51,367 | $51,909 | $53,527 | $55,006 |
| Total Assets | $178,233 | $168,230 | $164,656 | $163,619 | $159,798 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 60,279 | 47,650 | 43,167 | 35,634 | 34,933 |
| Accrued Expenses | 27,435 | 24,297 | 20,639 | 22,785 | 22,892 |
| TOTAL | $94,939 | $79,351 | $70,962 | $65,580 | $64,778 |
| Non-Current Liabilities | |||||
| Long Term Debt | 79,867 | 78,611 | 77,400 | 76,195 | 75,023 |
| Other Non-Current Liabilities | 28,341 | 26,553 | 32,014 | 34,118 | 28,982 |
| TOTAL | $108,208 | $105,164 | $109,414 | $110,313 | $104,005 |
| Total Liabilities | $203,147 | $184,515 | $180,376 | $175,893 | $168,783 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 101,916 | 99,983 | 98,839 | 98,381 | 93,505 |
| Common Shares | 10 | 10 | 10 | 10 | 9 |
| Retained earnings | -283,700 | -273,911 | -271,419 | -263,911 | -247,407 |
| Other shareholders' equity | -19 | -19 | -19 | -19 | -19 |
| TOTAL | $-24,914 | $-16,285 | $-15,720 | $-12,274 | $-8,985 |
| Total Liabilities And Equity | $178,233 | $168,230 | $164,656 | $163,619 | $159,798 |